HB Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.67M Buy
109,993
+22,867
+26% +$1.33M 0.04% 211
2025
Q4
$4.7M Buy
87,126
+9,429
+12% +$454K 0.03% 255
2025
Q3
$3.5M Buy
77,697
+9,507
+14% +$444K 0.02% 301
2025
Q2
$3.16M Sell
68,190
-21,852
-24% -$1.07M 0.03% 287
2025
Q1
$5.49M Buy
90,042
+16,500
+22% +$962K 0.05% 214
2024
Q4
$4.16M Buy
73,542
+11,023
+18% +$616K 0.04% 182
2024
Q3
$3.23M Sell
62,519
-11,974
-16% -$562K 0.03% 209
2024
Q2
$3.09M Buy
74,493
+4,692
+7% +$210K 0.04% 201
2024
Q1
$3.79M Buy
69,801
+4,451
+7% +$227K 0.05% 172
2023
Q4
$3.35M Sell
65,350
-3,413
-5% -$179K 0.05% 166
2023
Q3
$3.99M Buy
68,763
+5,651
+9% +$346K 0.06% 145
2023
Q2
$4.04M Buy
63,112
+5,879
+10% +$394K 0.06% 145
2023
Q1
$3.97M Sell
57,233
-1,872
-3% -$132K 0.07% 141
2022
Q4
$4.25M Buy
59,105
+8,089
+16% +$610K 0.08% 125
2022
Q3
$3.63M Sell
51,016
-1,598
-3% -$116K 0.08% 124
2022
Q2
$4.05M Buy
52,614
+16,395
+45% +$1.25M 0.08% 116
2022
Q1
$2.65M Buy
36,219
+6,256
+21% +$420K 0.05% 155
2021
Q4
$1.87M Buy
+29,963
New +$1.76M 0.04% 166

Other funds holding BMY

HB Wealth Management's BMY Position: Q1 2026 in Review

HB Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 26% in Q1 2026, buying an estimated $1.33M and bringing the position to 109,993 shares worth $6.67M. The position accounts for 0.04% of the portfolio, ranked #211.

HB Wealth Management first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • HB Wealth Management held 109,993 shares of Bristol-Myers Squibb worth $6.67M as of Q1 2026.
  • HB Wealth Management bought 22,867 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.33M.
  • Bristol-Myers Squibb made up 0.04% of HB Wealth Management's portfolio in Q1 2026, its #211 holding.
  • HB Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on HB Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.